Uncategorized
Allergan reports Q2 net revenue increase
Allergan reported its second quarter 2017 operations performance, including total net revenues of $4 billion, which was a 9% increase from the same quarter a year earlier.The revenue growth was driven by Botox (onabotulinumtoxinA) and the Juvederm (injectible gel) collection, and the addition of Alloderm (tissue matrix) and CoolSculpting (cryolipolysis), according to a news release from Allergan.